This is worth an extra post - new research building on observations from Italy that men in treatment for prostate cancer fared much better in beating covid, while one would expect the cancer would make them fare worse.
Rushing back to the lab, they found out that a popular treatment for prostate cancer royally fucks up covid.
The pharma company behind the drug of course set up a study to test this against placebo. The trial subjects had an average WHO severity rating of 5.6, meaning they were all in need of oxigen/non-invasive ventilation.
Here's the
results:
Not only did the drug reduce mortality by
92%, it also took nine days off the patient's hospital stay, cut down ventilator use on a similar scale as it reduced mortality, leading to an overall reduction in pressure on ICUs.
Of course, this is science by press release, no pre-print or peer-reviewed paper is available. Also, this is a cancer medication, so expect some hefty side effects.
But the data against covid, unlike with remdesivir or others, is super strong. So let's hope it can be replicated.